Purchase of Aton spotlights HDAC inhibitors.
Garber
Ken
K
D000970:Antineoplastic Agents / Q000494:pharmacology; D001709:Biotechnology / Q000379:methods*; D002843:Chromatin / Q000378:metabolism; D015195:Drug Design; D004345:Drug Industry / Q000379:methods*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D002843:Chromatin; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors